Skip to search formSkip to main contentSkip to account menu

lofexidine

Known as: 1H-imidazole, 2-(1-(2,6-dichlorophenoxy)ethyl)-4,5-dihydro-, 2-(alpha-(2,6-Dichlorophenoxy)ethyl)2-imidazoline, lofexidine [Chemical/Ingredient] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
Lofexidine (BritLofex, Britannia) is an α 2 agonist used for opioid detoxification.1 We report one case of an increased QT… 
2003
2003
The efficacy of lofexidine/naloxone was compared with lofexidine/placebo in a double-blind, randomized, placebo-controlled trial… 
Review
2002
Review
2002
Objectives This paper presents the main findings of a systematic (Cochrane) review of the effectiveness of α2-adrenergic agonists… 
1999
1999
Data were collected on 1,074 opiate detoxifications conducted with lofexidine, from 40 drug dependency units in the United… 
1986
1986
Twenty-eight patients admitted to hospital for alcohol withdrawal were treated with lofexidine, an alpha adrenergic agonist of… 
1983
1983
In an open clinical trial, lofexidine, an alpha-noradrenergic agonist similar to clonidine, was administered to 30 opiate… 
1981
1981
Abstract: Clonidine (0.01 to 0.16 mg/kg) and lofexidine (0.01 to 0.64 mg/kg) produced a dose‐dependent inhibition of diarrhea…